Research Library
LIMITED / EMERGING

Bronchogen

Also known as: Bronchogen, AEDL, Ala-Glu-Asp-Leu

Peptide SignalingOther / Emerging Research
ClassificationShort peptide bioregulator identified as the tetrapeptide Ala-Glu-Asp-Leu (AEDL).
SequenceAla-Glu-Asp-Leu (AEDL)
FormulaC18H30N4O9
Molecular weight~446.5 g/mol
CAS857267-12-0
PubChemPubChem CID 11690869 (verified chemical record)
Catalog / SKUBronchogen · MX-BRONCHOG-020 · 20 mg
TargetsPeptide bioregulator research (limited characterization)

Molecular Overview

Bronchogen is a short peptide bioregulator identified as the tetrapeptide Ala-Glu-Asp-Leu (AEDL), with a verified PubChem chemical record.

Mechanistic Background

Independent mechanistic characterization is limited. Consult primary literature and product documentation.

What Researchers Study

The available bioregulator literature is limited and should be interpreted cautiously.

Evidence Landscape

Current evidence level: LIMITED / EMERGING. Preclinical evidence does not equate to demonstrated human efficacy.

Research Limitations

Chemical identity is verified; for a specific commercial lot, retain the supplier exact-lot COA and verify reported mass/purity against the reference identity.

Research Use Only

Molecularix Biolabs provides research materials for legitimate laboratory research. Information in this Research Library is provided for educational and scientific reference purposes and is not medical advice, treatment guidance, or a recommendation for human or veterinary use.